Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: Evidence for developmental, immediate early gene, and lesion response

Journal of Neuroscience

Volumn 17, Issue 11, 1997, Pages 4223-4235

  Rivera, Santiago ^a,b   Tremblay, Evelyne ^a   Timsit, Serge ^a   Canals, Oriol ^a   Ben Ari, Yezekiel ^a   Khrestchatisky, Michel ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Université Paris Descartes   (France)

Author keywords

astrocytes; brain seizures; extracellular matrix; immediate early gene; neuronal death; protease inhibitor; TIMP 1; tissue remodeling

Indexed keywords

KAINIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; GENE INDUCTION; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE;

EID: 0030916121     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-11-04223.1997     Document Type: Article

References (32)

1. Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ (1990) Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50:2322-2329.
2. Apte SS, Mattel M-G, Olsen BR (1994) Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP-3 gene to chromosome 22. Genomics 19:86-90.
3. Ben-Ari Y, Tremblay E, Ottersen OP (1980) Injections of kainic acid into the amygdaloid complex of the rat: an electrographic, clinical, and histological study in relation to the pathology of epilepsy. Neuroscience 5:515-528.
4. Ben-Ari Y, Tremblay E, Riche D, Ghilini G, Naquet R (1981) Electrographic, clinical, and pathological alterations following systemic administration of kainic acid, bicuculline, or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6:1361-1391.
5. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L (1991) Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97:679-685.
6. Bugno M, Graeve L, Gatsios P, Koj A, Heinrich PC, Travis J, Kordula T (1995) Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res 23:5041-5047.
7. Bugra K, Pollard H, Charton G, Moreau J, Ben-Ari Y, Khrestchatisky M (1994) aFGF, bFGF, and fig mRNAs show distinct patterns of induction in the hippocampus following kainate-induced seizures. Eur J Neurosci 6:58-66.
8. Cawston T, Galloway W, Mercer E, Murphy G, Reynolds J (1981) Purification of rabbit bone inhibitor of collagenase. Biochem J 195:159-165.
9. Chen Z-L, Yoshida S, Kato K, Momota Y, Suzuki J, Tanaka T, Ito J, Nishino H, Aimoto S, Kiyama H, Shiosaka S (1995) Expression and activity-dependent changes of a novel limbic serine protease gene in the hippocampus. J Neurosci 15:5088-5097.
10. Chua CC, Chua BHL (1990) Tumor necrosis factor-α induces mRNA for collagenase and TIMP in human skin fibroblasts. Connect Tissue Res 25:161-170.
11. Dayer J-M, Burger D (1994) Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur Cytokine Netw 5:563-571.
12. de Bock F, Dornand J, Rondouin G (1996) Release of TNFα in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. NeuroReport 7:1125-1129.
13. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR, Murphy G, Reynolds JJ (1985) Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318:66-69.
14. Dugich-Djordjevic MM, Tocco G, Willoughby DA, Najm I, Pasinetti G, Thompson RF, Baudry M, Lapchak PA, Hefti F (1992) BDNF mRNA expression in the developing rat brain following kainic acid-induced seizure activity. Neuron 8:1127-1138.
15. Edwards DR, Parfett CL, Denhardt DT (1985) Transcriptional regulation of two serum-induced RNAs in mouse fibroblasts: equivalence of one species to B2 repetitive elements. Mol Cell Biol 5:3280-3288.
16. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty JP, Angel P, Heath JK (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904.
17. Edwards DR, Rocheleau H, Sharma R, Wills A, Cowie A, Hassell J, Heath JK (1992) Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim Biophys Acta 1171:41-55.
18. Emonard H, Grimaud J (1990) Matrix metalloproteinases. A review. Cell Mol Biol 36:131-153.
19. Ferhat L, Represa A, Zouaoui-Aggoun D, Ferhat W, Ben-Ari Y, Khrestchatisky M (1997) FGF-2 induces nerve growth factor expression in cultured rat hippocampal neurons. Eur J Neurosci, in press.
20. Frey U, Muller M, Kuhl D (1996) A different form of long-lasting potentiation revealed in tissue plasminogen activator mutant mice. J Neurosci 16:2057-2063.
21. Gall CM, Berschauer R, Isackson PJ (1994) Basic fibroblast growth factor mRNA is increased in forebrain neurons and glia following recurrent limbic seizures. Mol Brain Res 21:190-205.
22. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA, Leary AC, Brown EL, Orr EC, Clark SC (1985) Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 315:768-771.
23. Giraudon P, Thomasset N, Bernard A, Verrier B, Belin MF (1995) Induction of MMP9 (92 kDA gelatinase) activity and expression of tissue inhibitor of metalloproteinases-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-1. Eur J Neurosci 7:841-848.
24. Goto K, Ishige A, Sekiguchi K, Iizuka S, Sugimoto A, Yuzurihara M, Aburada M, Hosoya E, Kogure K (1990) Effects of cycloheximide on delayed neuronal death in rat hippocampus. Brain Res 534:105-116.
25. Gottschall PE, Yu X (1995) Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 64:1513-1520.
26. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298:29-32.
27. Hodgson J (1995) Remodeling MMPIs. Biotechnology 13:554-557.
28. Hughes P, Beilharz E, Gluckman P, Dragunow M (1993) Brain-derived neurotrophic factor is induced as an immediate early gene following N-methyl-D-aspartate receptor activation. Neuroscience 57:319-328.
29. Jonec V, Wasterlain GC (1979) Effects of inhibitors of protein synthesis on the development of kindled seizures in rats. Exp Neurol 66:524-532.
30. Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT (1989) Antisense RNA-induccd reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243:947-950.
31. Lauterborn JO, Rivera S, Stinis CT, Hayes VY, Isackson PJ, Gall CM (1996) Differential effects of protein synthesis inhibition on the activity-dependent expression of BDNF transcripts: evidence for immediate early gene responses from specific promoters. J Neurosci 16:7428-7436.
32. Leco JK, Khokha R, Pavloff N, Hawkes SP, Edwards DR (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269:9352-9360.